Get the Stockscreener App
118.66
0.85%
1.00
Overview
News
Price History
Option Chain
Financials
Why ZTS Down?
Discussions
Forecast
Dividend History
Zoetis Inc stock is traded at $118.66, with a volume of 4.99M.
It is up +0.85% in the last 24 hours and down -2.14% over the past month.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
See More
Previous Close:
$117.66
Open:
$119.19
24h Volume:
4.99M
Relative Volume:
1.25
Market Cap:
$52.29B
Revenue:
$9.40B
Net Income/Loss:
$2.65B
P/E Ratio:
19.99
EPS:
5.935
Net Cash Flow:
$2.24B
1W Performance:
+0.01%
1M Performance:
-2.14%
6M Performance:
-29.71%
1Y Performance:
-33.65%
1-Day Range:
$118.21
$121.08
1-Week Range:
$115.59
$121.08
52-Week Range:
$115.25
$181.85
Zoetis Inc Stock (ZTS) Company Profile
Compare ZTS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
118.66 | 51.85B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.33 | 45.46B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.52 | 42.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.79 | 34.62B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
493.99 | 21.03B | 3.08B | 1.24B | 1.07B | 25.61 |
Zoetis Inc Stock (ZTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Equal Weight |
| Nov-21-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jul-17-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jun-18-25 | Downgrade | Stifel | Buy → Hold |
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
| Jul-25-24 | Initiated | BTIG Research | Buy |
| Jan-12-24 | Reiterated | Stifel | Buy |
| Dec-19-23 | Resumed | Jefferies | Buy |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-08-21 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-08-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Sep-21-20 | Initiated | Atlantic Equities | Overweight |
| Aug-14-20 | Upgrade | Edward Jones | Hold → Buy |
| Aug-12-20 | Downgrade | Gabelli & Co | Buy → Hold |
| May-27-20 | Initiated | Jefferies | Buy |
| Jan-10-20 | Initiated | Raymond James | Mkt Perform |
| Sep-09-19 | Initiated | Goldman | Buy |
| Jul-01-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jun-11-19 | Initiated | Barclays | Overweight |
| May-23-19 | Initiated | Guggenheim | Buy |
| May-03-19 | Downgrade | Gabelli & Co | Buy → Hold |
| Mar-20-19 | Initiated | SunTrust | Hold |
| Mar-04-19 | Upgrade | Stifel | Hold → Buy |
| Jan-23-19 | Initiated | UBS | Neutral |
| Oct-15-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-22-18 | Downgrade | Stifel | Buy → Hold |
| Aug-03-18 | Reiterated | Stifel | Buy |
| Apr-19-18 | Reiterated | Citigroup | Buy |
| Mar-19-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Feb-16-18 | Reiterated | Stifel | Buy |
| Jan-04-18 | Upgrade | Citigroup | Neutral → Buy |
View All
Zoetis Inc Stock (ZTS) Latest News
Zoetis Inc. $ZTS Shares Purchased by BI Asset Management Fondsmaeglerselskab A S - MarketBeat
Zoetis Inc. $ZTS Shares Sold by Banque Transatlantique SA - MarketBeat
HSBC cuts Zoetis Inc. (ZTS)’s price target to $140 from $180, keeps buy rating - MSN
HSBC Cuts Zoetis Inc. (ZTS)’s Price Target To $140 From $180, Keeps Buy Rating - Insider Monkey
Occudo Quantitative Strategies LP Takes Position in Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc. $ZTS Holdings Lifted by Quantinno Capital Management LP - MarketBeat
Soros Capital Management LLC Purchases 14,027 Shares of Zoetis Inc. $ZTS - MarketBeat
Sei Investments Co. Has $96.11 Million Holdings in Zoetis Inc. $ZTS - MarketBeat
CIBC Asset Management Inc Raises Stake in Zoetis Inc. $ZTS - MarketBeat
Diversify Advisory Services LLC Buys 12,903 Shares of Zoetis Inc. $ZTS - MarketBeat
Alliancebernstein L.P. Has $584.04 Million Position in Zoetis Inc. $ZTS - MarketBeat
Is Zoetis Now an Opportunity After Its 2025 Share Price Pullback? - Yahoo Finance
Zoetis Inc. (ZTS) Announces First Quarter 2026 Dividend - GuruFocus
Zoetis raises quarterly dividend by 6% to $0.53 per share - Investing.com
Zoetis Ups Quarterly Dividend to $0.53 per Share, Payable Mar. 3 to Holders of Record on Jan. 20 - marketscreener.com
Should Health Canada’s Portela Approval Shape How Zoetis (ZTS) Investors View Its OA Innovation Strategy? - simplywall.st
Zoetis declares first quarter 2026 dividend; board approves 6% payment increase - marketscreener.com
Zoetis Declares First Quarter 2026 Dividend; Board Approves 6% Payment Increase - Business Wire
Zoetis Inc. $ZTS Shares Acquired by BNP Paribas - MarketBeat
Is Zoetis Inc ZOE a good long term investmentEarnings Per Share Trends & Minimal Capital Trading Tips - earlytimes.in
Zoetis Inc ZOE Stock Analysis and ForecastHigh Beta Stocks & Outstanding Return Portfolio - earlytimes.in
HSBC Adjusts Zoetis Price Target to $140 From $180, Maintains Buy Rating - marketscreener.com
State Street Corp Has $3.08 Billion Holdings in Zoetis Inc. $ZTS - MarketBeat
Daiwa Securities Group Inc. Boosts Stock Position in Zoetis Inc. $ZTS - MarketBeat
Zoetis (ZTS) Receives 'Equal-Weight' Rating from Barclays with a $136 Target | ZTS Stock News - GuruFocus
Zoetis Inc's (ZTS) Innovation Engine Remains Robust, Say's William Blair - Finviz
Zoetis Inc’s (ZTS) Innovation Engine Remains Robust, Say’s William Blair - Insider Monkey
Zoetis Inc. $ZTS Stock Position Lowered by Fayez Sarofim & Co - MarketBeat
Axa S.A. Sells 294,654 Shares of Zoetis Inc. $ZTS - MarketBeat
A New Veterinary Approval Offers Hope for Zoetis Investors - AD HOC NEWS
What's Driving the Market Sentiment Around Zoetis Inc? - Benzinga
Jump Financial LLC Sells 59,951 Shares of Zoetis Inc. $ZTS - MarketBeat
Cerity Partners LLC Increases Stock Holdings in Zoetis Inc. $ZTS - MarketBeat
California Public Employees Retirement System Cuts Stock Position in Zoetis Inc. $ZTS - MarketBeat
First Trust Advisors LP Trims Stock Holdings in Zoetis Inc. $ZTS - MarketBeat
Zoetis’ 50% Decline Plants the Seeds of a Recovery - Investing.com
Animal Vaccines Market Top key Players 2035 | Vetoquinol, Heska - openPR.com
Edgestream Partners L.P. Has $1.73 Million Stake in Zoetis Inc. $ZTS - MarketBeat
Amundi Has $439.04 Million Stake in Zoetis Inc. $ZTS - MarketBeat
1832 Asset Management L.P. Acquires 9,472 Shares of Zoetis Inc. $ZTS - MarketBeat
Zoetis (NYSE:ZTS) Shares Unloaded Sen. Markwayne Mullin - MarketBeat
Zoetis Inc. stock underperforms Friday when compared to competitors - MarketWatch
Zoetis (ZTS) Gains Health Canada Approval for New Cat Osteoarthritis Treatment - GuruFocus
EBIT per share of Zoetis, Inc. Class A – GETTEX:ZOE - TradingView
Zoetis Says Health Canada Approves Long-Lasting Cat Osteoarthritis Drug - marketscreener.com
Zoetis receives Health Canada approval for feline arthritis therapy By Investing.com - Investing.com Australia
Zoetis receives Health Canada approval for feline arthritis therapy - Investing.com
Earnings are growing at Zoetis (NYSE:ZTS) but shareholders still don't like its prospects - Yahoo Finance
Zoetis receives Health Canada approval for Portela (Relfovetmab injection) - marketscreener.com
Zoetis Receives Health Canada Approval for Portela™(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats - Bakersfield.com
(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats - Business Wire
Zoetis Inc Stock (ZTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.42%
1.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):